Extent, pattern, and prognostic value of MGMT promotor methylation: does it differ between glioblastoma and IDH-wildtype/TERT-mutated astrocytoma?

INTRODUCTION: The cIMPACT-NOW update 6 first introduced glioblastoma diagnosis based on the combination of IDH-wildtype (IDHwt) status and TERT promotor mutation (pTERTmut). In glioblastoma as defined by histopathology according to the WHO 2016 classification, MGMT promotor status is associated with...

Descripción completa

Detalles Bibliográficos
Autores principales: Teske, Nico, Karschnia, Philipp, Weller, Jonathan, Siller, Sebastian, Dorostkar, Mario M., Herms, Jochen, von Baumgarten, Louisa, Tonn, Joerg Christian, Thon, Niklas
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2021
Materias:
Clinical Study
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8816375/
https://www.ncbi.nlm.nih.gov/pubmed/34902093
http://dx.doi.org/10.1007/s11060-021-03912-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8816375/
https://www.ncbi.nlm.nih.gov/pubmed/34902093
http://dx.doi.org/10.1007/s11060-021-03912-6

Ejemplares similares